Log on / register
Feedback | Support | My details
Gene expression variation in Down's syndrome mice allows prioritization of candidate genes.
Sultan M, Piccini I, Balzereit D, Herwig R, Saran NG, Lehrach H, Reeves RH, Yaspo ML
Genome Biol 2007, 8:R91
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.
Canzonetta C, Mulligan C, Deutsch S, Ruf S, O'Doherty A, Lyle R, Borel C, Lin-Marq N, Delom F, Groet J, Schnappauf F, De Vita S, Averill S, Priestley JV, Martin JE, Shipley J, Denyer G, Epstein CJ, Fillat C, Estivill X, Tybulewicz VL, Fisher EM, Antonarakis SE, Nizetic D
Am J Hum Genet 2008 Sep, 83:388-400
[PubMed Central] [PubMed] [Related articles]

2.
Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies.
Ortutay C, Vihinen M
Nucleic Acids Res 2009 Feb, 37:622-8
[PubMed Central] [PubMed] [Related articles]

3.
Down syndrome--recent progress and future prospects.
Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM
Hum Mol Genet 2009 Apr 15, 18:R75-83
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.